Zymeworks Inc. (ZYME)
NASDAQ: ZYME · Real-Time Price · USD
23.26
+0.38 (1.66%)
At close: Jun 15, 2026, 4:00 PM EDT
23.25
-0.01 (-0.04%)
Pre-market: Jun 16, 2026, 8:51 AM EDT
Zymeworks Employees
Zymeworks had 243 employees as of March 31, 2026. The number of employees decreased by 56 or -18.73% compared to the same quarter last year.
Employees
243
Change
-56
Growth
-18.73%
Revenue / Employee
$334,416
Profits / Employee
-$422,453
Market Cap
1.70B
Employees Chart
Employees History
Related Stocks
| Company Name | Employees |
|---|---|
| Ascentage Pharma Group International | 767 |
| Recursion Pharmaceuticals | 600 |
| Intellia Therapeutics | 377 |
| Nuvation Bio | 307 |
| Biohaven | 274 |
| Innoviva | 159 |
| Septerna | 130 |
| AnaptysBio | 104 |
ZYME News
- 1 day ago - Zymeworks presents new clinical data on Phase 1 study of ZW191 - TheFly
- 1 day ago - Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting ADC ZW191 at ESMO Gynaecological Cancers Congress 2026 - GlobeNewsWire
- 7 days ago - Zymeworks assumed with a Buy at Truist - TheFly
- 13 days ago - Zymeworks Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Zymeworks authorizes share repurchase program of up to $125M - TheFly
- 4 weeks ago - Zymeworks Announces Share Repurchase Program of up to $125 Million of its Common Stock - GlobeNewsWire
- 4 weeks ago - Zymeworks Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Zymeworks reports Q1 EPS (59c), consensus (10c) - TheFly